Works matching IS 0008543X AND DT 2020 AND VI 126 AND IP 20


Results: 25
    1
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 20, p. 4532, doi. 10.1002/cncr.33071
    By:
    • McPherson, Victor;
    • Reardon, Brendan;
    • Bhayankara, Aravind;
    • Scott, Sasinya N.;
    • Boyd, Mariel E.;
    • Garcia‐Grossman, Ilana R.;
    • Regazzi, Ashley M.;
    • McCoy, Asia S.;
    • Kim, Philip H.;
    • Al‐Ahmadie, Hikmat;
    • Ostrovnaya, Irina;
    • Roth, Andrew J.;
    • Farooki, Azeez;
    • Berger, Michael F.;
    • Rosenberg, Jonathan E.;
    • Solit, David B.;
    • Van Allen, Eliezer;
    • Milowsky, Matthew I.;
    • Bajorin, Dean F.;
    • Iyer, Gopa
    Publication type:
    Article
    19
    20

    A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.

    Published in:
    2020
    By:
    • Zhang, Tian;
    • Harrison, Michael R.;
    • O'Donnell, Peter H.;
    • Alva, Ajjai S.;
    • Hahn, Noah M.;
    • Appleman, Leonard J.;
    • Cetnar, Jeremy;
    • Burke, John M.;
    • Fleming, Mark T.;
    • Milowsky, Matthew I.;
    • Mortazavi, Amir;
    • Shore, Neal;
    • Sonpavde, Guru P.;
    • Schmidt, Emmett V.;
    • Bitman, Bojena;
    • Munugalavadla, Veerendra;
    • Izumi, Raquel;
    • Patel, Priti;
    • Staats, Janet;
    • Chan, Cliburn
    Publication type:
    journal article
    21
    22
    23
    24
    25

    Issue Information.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 20, p. 4435, doi. 10.1002/cncr.32108
    Publication type:
    Article